Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390

Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in Brain

David R. Burt, Ian Creese, Solomon H. Snyder · Science · 1977 · 1K citations

Medicine, Neuroscience, Pharmacology +17

SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.

Louis C. Iorio, A Barnett, Frederick H. Leitz et al. · Journal of Pharmacology and Experimental Therapeutics · 1983 · 897 citations

Medicine, Pharmacology, Psychiatry +15

Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics

A. V. Christensen, J. Arnt, John Hyttel et al. · Life Sciences · 1984 · 376 citations

Medicine, Neuroscience, Pharmacology +12

Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors

Simon Fleminger, N.M.J. Rupniak, M.D. Hall et al. · Biochemical Pharmacology · 1983 · 82 citations

Medicine, Neuroscience, Pharmacology +10